# Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis

> **NCT00267852** · — · COMPLETED · sponsor: **Wyeth is now a wholly owned subsidiary of Pfizer** · enrollment: 152 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **OTHER:** as clinical practice

## Key facts

- **NCT ID:** NCT00267852
- **Lead sponsor:** Wyeth is now a wholly owned subsidiary of Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** 152 (ACTUAL)
- **Last updated:** 2011-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00267852

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00267852, "Study Evaluating the Clinical Remission in Early Aggressive Rheumatoid Arthritis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00267852. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*